February 22, 2015 | NYU Langone Medical Center and the Technion-Israel Institute of Technology announced that they received a $9 million gift from Laura and Isaac Perlmutter to fund two, major joint cancer research endeavors. The institutions believe that there is potentially far-reaching impact for the research projects in question to advance cancer research. The first $3 million grant will finance six cancer-focused research projects conducted by researchers at NYU Langone and the Technion. The remaining $6 million will be used to establish a state-of-the-art research facility on Technion’s campus in Israel that will support these and other research projects– and which will have a principal focus on the emerging field of cancer metabolomics. NYU Langone is a world-renowned leader in the investigation and treatment of cancer. The Technion is one of Israel’s leading academic and research centers and a top-ranked science and technology global research university.
Related posts

Israel And UAE Ink New Deal To Connect Ports Via Land Bridge

Dubbing Startup Unveils Innovative Fair Pay Plan For Voice Actors

Non-Profit Launches 10M Shekel Fund For Israeli Small Businesses

Facebook comments